We are live on ! Find out more
PJP icon

Invesco Pharmaceuticals ETF
PJP

93 hedge funds and large institutions have $59M invested in Invesco Pharmaceuticals ETF in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

14% more capital invested

Capital invested by funds: $51.8M → $59M (+$7.22M)

1% more funds holding

Funds holding: 92 → 93 (+1)

0.05% less ownership

Funds ownership: 22.28% → 22.23% (-0.05%)

17% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 23

Holders
93
Holders Change
+1
Holders Change %
+1.09%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
19
Reduced
23
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$730K
2
Goldman Sachs
Goldman Sachs
New York
+$635K
3
LPL Financial
LPL Financial
California
+$510K
4
Citadel Advisors
Citadel Advisors
Florida
+$477K
5
WI
WBI Investments
New Jersey
+$472K

Top Sellers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$799K
2
Wells Fargo
Wells Fargo
California
-$651K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$545K
4
TRCT
Tower Research Capital (TRC)
New York
-$408K
5
SWGC
Summit Wealth Group (Colorado)
Colorado
-$366K
Name Holding Trade Value Shares
Change 		Change in
Stake
CBT
76
Crews Bank & Trust
Florida
$9.25K – – –
FGA
77
Fortis Group Advisors
New Jersey
$9.25K – – –
WANY
78
Wealthspire Advisors (New York)
New York
$8.32K +$7.88K +90 New
National Bank of Canada
79
National Bank of Canada
Quebec, Canada
$6.57K – – –
AAG
80
Armstrong Advisory Group
Massachusetts
$5.55K – – –
BTC
81
Bank & Trust Company
Illinois
$5.55K – – –
William Blair & Company
82
William Blair & Company
Illinois
$5.55K – – –
BTI
83
Blue Trust Inc
Georgia
$5.23K +$4.99K +57 New
ATS
84
Ashton Thomas Securities
New York
$5.09K – – –
Qube Research & Technologies (QRT)
85
Qube Research & Technologies (QRT)
United Kingdom
$5.09K – – –
SWM
86
Spire Wealth Management
Virginia
$4.78K – – –
1NWS
87
1 North Wealth Services
Maryland
$2.87K – – –
DAM
88
Delta Asset Management
Tennessee
$2.31K – – –
WT
89
Whittier Trust
California
$1.82K – – –
AUB
90
Atlantic Union Bankshares
Virginia
$1.6K – – –
PA
91
Parallel Advisors
California
$1.52K – – –
TRCT
92
Tower Research Capital (TRC)
New York
$1.39K -$408K -4,665 -100%
ADL
93
Asset Dedication LLC
California
$1.2K – – –
BNP Paribas Financial Markets
94
BNP Paribas Financial Markets
France
– -$799K -10,000 Closed
Susquehanna International Group
95
Susquehanna International Group
Pennsylvania
– -$545K -6,825 Closed
SWGC
96
Summit Wealth Group (Colorado)
Colorado
– -$366K -4,582 Closed
PSFG
97
Park Square Financial Group
Georgia
– -$83.9K -1,050 Closed
RDFA
98
Ritter Daniher Financial Advisory
Ohio
– -$20K -250 Closed
SVCP
99
Silicon Valley Capital Partners
California
– -$8.33K -104 Closed
FWM
100
FSA Wealth Management
Massachusetts
– -$4.96K -62 Closed
1 2 3
4

PJP Hedge Fund Activity: Q3 2025 in Review

93 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2025, worth a combined $59M — up 14% from $51.8M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new PJP positions and 7 closed out — a net gain of 1 holder — while 19 added to existing stakes and 23 trimmed.

The largest buyer was Ameriprise, adding an estimated $730K. The largest seller was BNP Paribas Financial Markets, exiting entirely with an estimated $799K sold.

  • 93 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2025, up from 92 in Q2 2025.
  • Funds reported $59M of Invesco Pharmaceuticals ETF stock for Q3 2025, up 14% quarter-over-quarter.
  • 8 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2025 and 7 closed out, a net change of +1 holder.
  • The largest Invesco Pharmaceuticals ETF buyer in Q3 2025 was Ameriprise, an estimated $730K added.
  • The largest Invesco Pharmaceuticals ETF seller in Q3 2025 was BNP Paribas Financial Markets, an estimated $799K sold.

Based on aggregated 13F filings for Q3 2025.